Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revolution Medicines Inc (NQ: RVMD )

40.02 -0.66 (-1.63%)
Streaming Delayed Price Updated: 12:33 PM EDT, Jun 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 445,660
Open 40.36
Bid (Size) 40.00 (3)
Ask (Size) 40.05 (1)
Prev. Close 40.68
Today's Range 39.39 - 40.55
52wk Range 15.44 - 41.20
Shares Outstanding 106,313,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
https://seekingalpha.com/news/4111624-goldman-sachs-raises-obesity-drug-market-estimate 
Via InvestorPlace
RVMD Stock Earnings: Revolution Medicines Beats EPS for Q1 2024
RVMD stock results show that Revolution Medicines beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace

Performance

YTD
+41.75%
+41.75%
1 Month
+2.47%
+2.47%
3 Month
+29.58%
+29.58%
6 Month
+66.94%
+66.94%
1 Year
+59.17%
+59.17%

More News

Read More
Top 3 Health Care Stocks That May Collapse In Q2
Via Benzinga
Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Revolution Medicines Inc. (NASDAQ: RVMD) Climbs to New 52-Week High
Via Investor Brand Network
Revolution Medicines's Earnings: A Preview
Via Benzinga
What's Going On With Revolution Medicines Stock?
Via Benzinga
Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Topics Stocks
Exposures US Equities
Morgan Stanley Maintains Equal-Weight Rating for Revolution Medicines: Here's What You Need To Know
Via Benzinga
Uncovering Noteworthy Technical Analysis Findings for REVOLUTION MEDICINES INC (NASDAQ:RVMD).
Via Chartmill
Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development
Via InvestorPlace
What 6 Analyst Ratings Have To Say About Revolution Medicines
Via Benzinga
Earnings Scheduled For November 6, 2023
Via Benzinga
Preview: Revolution Medicines's Earnings
Via Benzinga
Why Revolution Medicines Stock Is Crashing Today
Via The Motley Fool
Earnings Scheduled For February 26, 2024
Via Benzinga
3 Biotech Stocks That Could Boom or Bust by 2025
Via InvestorPlace
Cancer Player Revolution Medicines Gets Bullish Rating: Here's Details
Via Benzinga
Crude Oil Falls Sharply; Apollomics Shares Plunge
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Turns Higher; Akumin Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
FMC, Li-Cycle Holdings, Okta And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Revolution Medicines Crashes 39% On Lackluster Test Results In Cancer Treatment
Via Investor's Business Daily
Dow Falls Over 100 Points; Chicago Fed National Activity Index Increases In September
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.